Sodium Deposition in Soft Tissues of Patients with Kidney Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6+
SponsorChris McIntyre

About this trial

Sodium (Na+) hemostasis is abnormal in CKD patients, and this element can be deposited in the skin, muscle, and skeleton - to cope with long term sodium loading. It is known that sodium stored in this non-osmotically active way, is profoundly inflammatory. Furthermore, inflammation has been associated with several uremic symptoms. The investigators will use novel Na+ MRI imaging to examine the Na+ deposition in the skin, muscle, and skeleton of five groups:1) chronic in-center hemodialysis patients, 2) chronic peritoneal dialysis patients, 3) adult and paediatric patients with CKD stage 1-5 and 4) heart failure patients with and without renal dysfunction 5) sex and age-matched healthy adult and paediatric controls. Additionally, they will investigate the association between sodium deposition in these tissues with uremic symptomatology and biochemical markers of metabolism.

Eligibility criteria

Qualifiers

Age greater than or equal to 6 years

For patients on maintenance hemodialysis or peritoneal dialysis: more than 3 months duration of therapy

For patients with CKD stage 1-5: CKD stage 1-5 and no indications to start dialysis

For heart failure patients: with or without renal dysfunction

Disqualifiers

Pregnant, breastfeeding or intending pregnancy

Unable to give consent or understand written information

Contraindication to MRI study

Trial design

Treatments tested in this trial

  • Measuring sodium content

Treatment groups

400 Participants
are divided into 5 treatment groups

Sponsors and collaborators

Chris McIntyre

Lead sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sponsor institution